Literature DB >> 17589628

Quality of life after surgical myocardial revascularization, angioplasty or medical treatment.

Myrthes Emy Takiuti1, Whady Hueb, Shirley Borghetti Hiscock, Célia Regina Simões da Rocha Nogueira, Priscyla Girardi, Fabio Fernandes, Desiderio Favarato, Neuza Lopes, Jorge Chiquie Borges, Aécio Flávio Teixeira de Góis, José Antonio Franchini Ramires.   

Abstract

BACKGROUND: Although the clinical benefits of coronary interventions seem to be confirmed, their effects on quality of life (QoL) are still scarcely studied.
OBJECTIVE: To assess the QoL in multivessel coronary disease in patients randomly undergoing surgery, angioplasty or medical treatment.
METHODS: The Short-Form Health Survey (SF-36) questionnaire was answered by 483 patients. Of these, 161 underwent surgical revascularization, 166 underwent angioplasty, and 153 were medically treated.
RESULTS: At baseline, 86% of the patients referred angina, 34% referred infarction, and 32% were smokers. Medical Treatment: 12 patients (7.7%) had AMI, 24 (15.3%) underwent surgery, and 19 (12.1%) died. In addition, 5 (3.2%) had stroke, and 40 (25.6%) had angina. As regards the mental component, 64.1% and 30.8% had their condition improved and worsened, respectively. As regards the physical component, 70.5% and 27.6% had their condition improved and worsened, respectively. SURGERY: 13 patients (8.1%) had AMI, 2 (1.2%) underwent surgery, and 12(7.4%) died. Also, 9 (5.6%) had stroke and 30 (18.6%) had angina. As regards the mental component, 72.7 % and 25.5% had their condition improved and worsened, respectively. As regards the physical component, 82.6% and 16.1% had their condition improved and worsened, respectively. Angioplasty: 18 patients (10.9%) had AMI, 51 (30.7%) underwent interventions, and 18 (19.9%) died. Additionally, six (3.6%) presented stroke and 35 (21%) reported angina. As regards the mental component, 66.9% and 26.5% had their condition improved and worsened, respectively. As regards the physical component, 77.1% and 20.5% had their condition improved and worsened, respectively.
CONCLUSION: Improvement was observed in all domains and in the three therapeutic modalities. Comparatively, surgery had provided a better quality of life after a four-year follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17589628     DOI: 10.1590/s0066-782x2007000500007

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  Quality of life of patients with first-time AMI: a descriptive study.

Authors:  Mandreker Bahall; Katija Khan
Journal:  Health Qual Life Outcomes       Date:  2018-02-13       Impact factor: 3.186

Review 2.  Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial.

Authors:  Sara Michelly Gonçalves Brandão; Paulo Cury Rezende; Hans-Peter Brunner-La Rocca; Yang Ting Ju; Antonio Carlos Pedroso de Lima; Myrthes Emy Takiuti; Whady Hueb; Edimar Alcides Bocchi
Journal:  Cost Eff Resour Alloc       Date:  2018-11-03

3.  Quality of Life in Cardiovascular Surgery: Elaboration and Initial Internal Validation of a Quality of Life Questionnaire.

Authors:  Marina Macedo Kuenzer Bond; Jenny Lourdes Rivas de Oliveira; Luiz Carlos Bento de Souza; Pedro Silvio Farsky; Vivian Lerner Amato; Dorival Julio Della Togna; Samira Kaissar Ghorayeb; Magaly Arrais Dos Santos
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct

Review 4.  Recent trends in Brazilian medical research. An overview.

Authors:  Mauricio Rocha-e-Silva
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

5.  Depression after CABG: a prospective study.

Authors:  Joana Kátya Veras Rodrigues Sampaio Nunes; José Albuquerque de Figueiredo Neto; Rosângela Maria Lopes de Sousa; Vera Lívia Xavier de Castro Costa; Flor de Maria Araújo Mendonça Silva; Ana Flávia Lima Teles da Hora; Edna Lúcia Coutinho da Silva; Lívia Mariane Castelo Branco Reis
Journal:  Rev Bras Cir Cardiovasc       Date:  2013 Oct-Dec

6.  Utility and quality-adjusted life-years in coronary artery disease: Five-year follow-up of the MASS II trial.

Authors:  Sara Michelly Gonçalves Brandão; Whady Hueb; Yang Ting Ju; Antonio Carlos Pedroso de Lima; Carisi Anne Polanczyk; Luciane Nascimento Cruz; Rosa Maria Rahmi Garcia; Myrthes Emy Takiuti; Edimar Alcides Bocchi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.